Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample
暂无分享,去创建一个
[1] S. Shenavandeh,et al. Assessment of hospitalization and mortality of scleroderma in-patients: a thirteen-year study , 2017, Reumatologia.
[2] J. Baker,et al. Predictors of inpatient mortality in patients with systemic sclerosis: a case control study , 2016, Clinical Rheumatology.
[3] R. Simms,et al. Systemic sclerosis , 2015, Nature Reviews Disease Primers.
[4] Nilanjana Bose,et al. Scleroderma renal crisis. , 2015, Seminars in arthritis and rheumatism.
[5] E. Krishnan,et al. Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria , 2015, Scandinavian journal of rheumatology.
[6] X. Corbella,et al. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. , 2014, Seminars in arthritis and rheumatism.
[7] C. Foocharoen,et al. Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis , 2013, Clinical Rheumatology.
[8] E. Feierl,et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database , 2010, Annals of the rheumatic diseases.
[9] E. Chakravarty,et al. Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. , 2007, Rheumatology.
[10] T. Medsger,et al. Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.
[11] B. Giraudeau,et al. Mycobacterium chelonae finger infection associated with Raynaud’s phenomenon , 2004, Annals of the rheumatic diseases.
[12] R. Silver,et al. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. , 2001, The Journal of rheumatology.
[13] J. W. Archer,et al. Inpatient Costs of Major Cardiovascular Events , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.